SQZ Biotechnologies Announces Confirmed Complete Response in HPV16 Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial investors.sqzbiotech.com/new…$SQZ
In recognition of #WorldDiabetesDay, we’re revisiting this #HowCellsWork episode, which looks at how immune tolerance therapies could change the treatment paradigm for #Type1Diabetes & improve patient quality of life. Cc @JDRF
At #mRNA2022 today, @ilkeremrahozay presented on how the Cell Squeeze® Technology can be used to generate Enhanced Antigen Presenting Cells (SQZ® eAPCs) that amplify CD8 T cell responses @mrnaconference
At #SITC22, we shared preclinical data showing that SQZ® eAPCs with mRNA encoding multiple linked antigens could represent a potential model for a personalized neoantigen medicine for mutations like #KRAS: buff.ly/3WQUNfx$SQZ#CellTherapy
We are pleased to share the Clinical Trials and Immunotherapy for Head and Neck Cancer webinar.
Presented by @SQZBiotech, SPOHNC and @hncalliance. Much thanks and appreciation to our guest speakers. youtu.be/JsEWMM-rh9w
We are happy to share the recording of the webinar, Clinical Trials and Immunotherapy for Head and Neck Cancer: 3 Different Perspectives (Presented by SQZ Biotechnologies, SPOHNC and Head and Neck Cancer Alliance)youtu.be/OG8P6Zhapjs
About 70% of oropharyngeal cancers are linked to human papillomavirus (HPV). In this #HowCellsWork episode, we explore how #HPV can cause #headandneckcancer:
Ragon Seminar Tuesday 10/25 at noon ET: Join us for a presentation by @ArmonSharei, CEO and founder @SQZBiotech.
Sign up for our seminar email list: eepurl.com/gY8tUP
Stephane Calmat, PhD, SQZ Director of Analytical Development, presents on "Early adoption of RMM technologies to enable novel cell therapies for patient needs" at @PDAonline Microbiology Conference Cc @MilliporeSigma
Preclinical data published in @FrontImmunol demonstrates that SQZ® Activating Antigen Carriers (AACs) have the potential to be an effective red blood cell-derived cancer #immunotherapy. Learn more: buff.ly/3SP86dM#celltherapy
We are proud to sponsor @HPVAnalCancer’s Patient Summit, a full day of expert sessions focused on #analcancer treatment, side effects, prevention, and community. Learn more & register at: tinyurl.com/ACFSummit22
Join SQZ CEO @ArmonSharei at #BiotechWeekBoston on 9/28 for a panel on “Beyond Rare Diseases - Overcoming the Challenges of Expanding to Larger Patient Populations with Cell and Gene Therapies” with @Atarabio & @BioCentriq buff.ly/3Ravq4a
It’s #WorldCancerResearchDay. Today and every day, we’re working to advance treatments for cancer patients. Learn more about how our clinical trials seek to put patients’ own immune systems to work to fight their cancer:
buff.ly/3doHpO5